Literature DB >> 22357415

Prevalence, awareness, treatment, and control of hypertension among herdsmen living at 4,300 m in Tibet.

Xingshan Zhao1, Shenshen Li, Sang Ba, Feng He, Nicole Li, Liang Ke, Xian Li, Christopher Lam, Lijing L Yan, Yujie Zhou, Yangfeng Wu.   

Abstract

BACKGROUND: Studies on blood pressure (BP) in high-altitude areas are scarce and the results are controversial. Tibetans live in regions at high altitudes, and data on the prevalence of hypertension in this population is not currently well known.
METHODS: All Tibetans aged 40 years and older living in the township of Yangbajing (4,300 m) in Tibet, China were invited to participate in the 2009 survey. BP was measured with electronic sphygmomanometers (calibrated by the results of a previous study). Histories of hypertension and medication use were collected through face-to-face interviews. Hypertension was defined as systolic BP (SBP) ≥140 mm Hg and/or diastolic BP (DBP) ≥90 mm Hg, or antihypertensive medication use in the past 2 weeks.
RESULTS: A total of 701 adults (aged 40-89, 42.9% male, 94.9% herdsmen) were recruited. The mean (s.d.) SBP/DBP was 146.6 (31.3)/92.0 (15.7) mm Hg and the prevalence of hypertension was 55.9%. Of note, 61.2% of those with hypertension had stage 2 hypertension (SBP ≥160 or DBP ≥100 mm Hg). At age 70 years and older, the mean (s.d.) SBP/DBP were 182.8 (30.9)/102.6 (13.4) mm Hg. Among those with hypertension (n = 392), only 19.9% were aware of their condition, 2.6% were taking medication, and only one participant had controlled BP.
CONCLUSION: According to our survey in Yangbajing, Tibetan adults aged 40 years and older living at high altitudes had high BP and prevalence of hypertension with low awareness, treatment, and control. Future studies are needed to clarify the association between BP, altitude, and other possible causes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22357415     DOI: 10.1038/ajh.2012.9

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  19 in total

1.  A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India.

Authors:  Maoyi Tian; Vamadevan S Ajay; Danzeng Dunzhu; Safraj S Hameed; Xian Li; Zhong Liu; Cong Li; Hao Chen; KaWing Cho; Ruilai Li; Xingshan Zhao; Devraj Jindal; Ishita Rawal; Mohammed K Ali; Eric D Peterson; Jiachao Ji; Ritvik Amarchand; Anand Krishnan; Nikhil Tandon; Li-Qun Xu; Yangfeng Wu; Dorairaj Prabhakaran; Lijing L Yan
Journal:  Circulation       Date:  2015-07-17       Impact factor: 29.690

Review 2.  Prevalence of hypertension and its relationship with altitude in highland areas: a systematic review and meta-analysis.

Authors:  Xin Zhang; Zhipeng Zhang; Runyu Ye; Qingtao Meng; Xiaoping Chen
Journal:  Hypertens Res       Date:  2022-06-15       Impact factor: 5.528

Review 3.  Systemic Hypertension at High Altitude.

Authors:  Offdan Narvaez-Guerra; Karela Herrera-Enriquez; Josefina Medina-Lezama; Julio A Chirinos
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

4.  Performance comparison among the major healthcare financing systems in six cities of the Pearl River Delta region, mainland China.

Authors:  Martin C S Wong; Harry H X Wang; Samuel Y S Wong; Xiaolin Wei; Nan Yang; Zhenzhen Zhang; Haitao Li; Yang Gao; Donald K T Li; Jinling Tang; Jiaji Wang; Sian M Griffiths
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

Review 5.  Systolic hypertension: an increasing clinical challenge in Asia.

Authors:  Jeong Bae Park; Kazuomi Kario; Ji-Guang Wang
Journal:  Hypertens Res       Date:  2014-12-11       Impact factor: 3.872

6.  Prevalence and Clustering of Cardiovascular Disease Risk Factors among Tibetan Adults in China: A Population-Based Study.

Authors:  Shaopeng Xu; Zepei Jiayong; Bin Li; Hong Zhu; Hong Chang; Wei Shi; Zhengxuan Gao; Xianjia Ning; Jinghua Wang
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

7.  Using a low-sodium, high-potassium salt substitute to reduce blood pressure among Tibetans with high blood pressure: a patient-blinded randomized controlled trial.

Authors:  Xingshan Zhao; Xuejun Yin; Xian Li; Lijing L Yan; Christopher T Lam; Shenshen Li; Feng He; Wuxiang Xie; Ba Sang; Gesang Luobu; Liang Ke; Yangfeng Wu
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

8.  Awareness Status of Chronic Disabling Neurological Diseases among Elderly Veterans.

Authors:  Ji-Ping Tan; Lin-Qi Zhu; Jun Zhang; Shi-Min Zhang; Xiao-Yang Lan; Bo Cui; Yu-Cheng Deng; Ying-Hao Li; Guang-Hua Ye; Lu-Ning Wang
Journal:  Chin Med J (Engl)       Date:  2015-05-20       Impact factor: 2.628

9.  A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale.

Authors:  Vamadevan S Ajay; Maoyi Tian; Hao Chen; Yangfeng Wu; Xian Li; Danzeng Dunzhu; Mohammed K Ali; Nikhil Tandon; Anand Krishnan; Dorairaj Prabhakaran; Lijing L Yan
Journal:  BMC Public Health       Date:  2014-09-06       Impact factor: 3.295

10.  The Expanding Burden of Elevated Blood Pressure in China: Evidence From Jiangxi Province, 2007-2010.

Authors:  Gang Xu; Junxiu Liu; Shiwei Liu; Haiming Zhou; Olubunmi Orekoya; Jie Liu; Yichong Li; Ji Tang; Chunlian Zhou; Jiuling Huang
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.